The Role of Menarcheal Age and Parity in the Development of Uterine Leiomyoma

Authors

  • Elvina Fawwaz Maharizdihar Universitas Muhammadiyah Surakarta
  • Yuni Prastyo Kurniati Universitas Muhammadiyah Surakarta

DOI:

https://doi.org/10.56741/hesmed.v4i03.1415


Keywords:

case-control study, menarche age, parity, reproductive risk factors, uterine leiomyoma

Abstract

Uterine leiomyoma is the most prevalent benign neoplasm of the female reproductive tract during the reproductive years; however, its precise etiology remains incompletely understood. Age at menarche and parity have been proposed as potential risk factors, although previous studies have reported inconsistent findings. This study aimed to evaluate the association between age at menarche and parity with the occurrence of uterine leiomyoma. This research employed a case-control design, in which uterine leiomyoma constituted the case group and adenomyosis served as the control group, conducted at PKU Muhammadiyah Hospital Surakarta. The study included 113 participants, comprising 73 cases of uterine leiomyoma and 40 cases of adenomyosis as controls, identified through histopathological records from 2023. Data were assessed using Chi-Square and logistic regression analyses. The findings revealed that most respondents experienced menarche at a normal age and were either primiparous or multiparous. Statistical testing demonstrated a significant association between age at menarche (p = 0.007; OR = 1.65, 95% CI = 1.414–1.939) and the incidence of uterine leiomyoma, whereas parity was not significantly associated (p = 0.384; OR = 1.509, 95% CI = 0.596–3.825). Future studies are recommended to include more balanced sample group proportions and additional risk factors to obtain a more comprehensive understanding of uterine leiomyoma etiology.

Downloads

Download data is not yet available.

Author Biographies

Elvina Fawwaz Maharizdihar, Universitas Muhammadiyah Surakarta

Elvina Fawwaz Maharizdihar is undergraduate medical student at the Faculty of Medicine, Universitas Muhammadiyah Surakarta. Her academic interest focuses on women’s reproductive health, particularly the role of menarcheal age and parity in the development of uterine leiomyoma. In addition to her studies, she also serves as a teaching assistant at the Laboratory of Anatomical Pathology, Faculty of Medicine, Universitas Muhammadiyah Surakarta. (email: elvinafawwazmaharizdihar1406@gmail.com).

Yuni Prastyo Kurniati, Universitas Muhammadiyah Surakarta

Yuni Prastyo Kurniati is a medical specialist in Anatomical Pathology and currently serves as the Head of the Anatomical Pathology Laboratory at the Faculty of Medicine, Universitas Muhammadiyah Surakarta. She holds dual master’s degress in Anatomical Pathology (Sp.PA) and Health Management (M.M.Kes). Her academic expertise lies in anatomical pathology with a particular research focus on tumor and malignancies, especially in the bone and soft tissue cancers. She has authored several scientific publications in national and international journals, including her most notable article, “Analyzing socio-enviromental determinats of bone and soft tissue cancer in Indonesia”, publish in BMC Cancer (2024), an international Scopus and Web of Science indexed journal. In addition, she has contributed to various community service project and academic collaborations in the field of pathology and public heatlh. (email: ypk134@ums.ac.id)

References

A. S. Koltsova, O. A. Efimova, and A. A. Pendina, “A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity †,” Int. J. Mol. Sci., vol. 24, no. 6, 2023, doi: 10.3390/ijms24065752. DOI: https://doi.org/10.3390/ijms24065752

F. Fitriyanti and M. Machmudah, “Penurunan Intensitas Nyeri pada Pasien Mioma Uteri menggunakan Teknik Relaksasi dan Distraksi,” Ners Muda, vol. 1, no. 1, p. 40, 2020, doi: 10.26714/nm.v1i1.5502. DOI: https://doi.org/10.26714/nm.v1i1.5502

A. F. Fauzan Farma and Y. P. Kurniati, “Analysis of The Incidence of Uterine Leiomyoma Based on Body Mass Index and Neutrophil-Lymphocyte Ratio,” J. La Medihealtico, vol. 5, no. 5, pp. 998–1007, 2024, doi: 10.37899/journallamedihealtico.v5i5.1609. DOI: https://doi.org/10.37899/journallamedihealtico.v5i5.1609

E. Giuliani, S. As-Sanie, and E. E. Marsh, “Epidemiology and management of uterine fibroids,” Int. J. Gynecol. Obstet., vol. 149, no. 1, pp. 3–9, 2020, doi: 10.1002/ijgo.13102. DOI: https://doi.org/10.1002/ijgo.13102

N. S. Meilani et al., “ARTIKEL PENELITIAN Hubungan Usia dan Paritas dengan Kejadian Mioma Uteri di RSUD Al-Ihsan Provinsi Jawa Barat Tahun 2017,” vol. 2, no. 22, pp. 200–203, 2019, [Online]. Available: http://ejournal.unisba.ac.id/index.php/jiks DOI: https://doi.org/10.29313/jiks.v2i1.4346

P. A. Andriani, “Analisis Regresi Faktor Resiko Kejadian Mioma Uteri di RSUD dr. R. Goeteng Tarunadibrata Purbalingga,” Indones. J. Nurs. Res., vol. 1, no. 1, pp. 39–47, 2018, doi: 10.35473/ijnr.v1i1.7. DOI: https://doi.org/10.35473/ijnr.v1i1.7

M. Jamil and I. Andriani, “Penguatan Kemandirian Masyarakat Dalam Deteksi Dan Pemeriksaan Mioma Uteri,” J. Implementasi Pengabdi. Masy. Kesehat., vol. 5, no. 2 (Sept), pp. 41–44, 2023, doi: 10.33660/jipmk.v5i2.101. DOI: https://doi.org/10.33660/jipmk.v5i2.101

S. M. Ascher et al., “ACR Appropriateness Criteria® Fibroids,” J. Am. Coll. Radiol., vol. 19, no. 11, pp. S319–S328, 2022, doi: 10.1016/j.jacr.2022.09.019. DOI: https://doi.org/10.1016/j.jacr.2022.09.019

N. Rudiyanti and R. Imron, “Hubungan Usia Menarche Dan Paritas Dengan Mioma Uteri,” J. Keperawatan, vol. 12, no. 2, pp. 233–239, 2016, [Online]. Available: https://www.poltekkes-tjk.ac.id/ejurnal/index.php/JKEP/article/view/604

K. Putu, “Hubungan Usia Dan Paritas Dengan Kejadian Mioma Uteri di RSUD Wagaya Denpasar Tahun 2016-2017.,” Bali Heal. J., vol. 5, no. 2, 2020. DOI: https://doi.org/10.34063/bhj.v5i2.209

M. Maria Syl D. De La Cruz, Md, And Edward M. Buchanan, “Diagnosis and Management of Uterine Torsion,” Vet. Tech. Llamas Alpacas, Second Ed., pp. 247–251, 2023, doi: 10.1002/9781119860792.ch58. DOI: https://doi.org/10.1002/9781119860792.ch58

A. T. Hartoyo and N. Pangastuti, “Fibroid Uterus dan Infertilitas,” Cermin Dunia Kedokt., vol. 49, no. 3, pp. 143–146, 2022, doi: 10.55175/cdk.v49i3.208. DOI: https://doi.org/10.55175/cdk.v49i3.208

G. A. Vilos et al., “The Management of Uterine Leiomyomas,” J. Obstet. Gynaecol. Canada, vol. 37, no. 2, pp. 157–178, 2015, doi: 10.1016/S1701-2163(15)30338-8. DOI: https://doi.org/10.1016/S1701-2163(15)30338-8

A. Wozniak and S. Wozniak, “Ultrasonography of uterine leiomyomas,” Prz. Menopauzalny, vol. 16, no. 4, pp. 113–117, 2017, doi: 10.5114/pm.2017.72754. DOI: https://doi.org/10.5114/pm.2017.72754

S. Rokhgireh et al., “Hemoperitoneum due to bleeding from a vein overlying a subserous uterine myoma: A case report,” J. Med. Case Rep., vol. 14, no. 1, pp. 14–17, 2020, doi: 10.1186/s13256-020-02383-z. DOI: https://doi.org/10.1186/s13256-020-02383-z

H. Reza, N. A. Andriani, and S. A. Suwantari, “Cervical Leiomyoma in Pre-Menopausal Woman: A Case Report,” J. Biomed. Transl. Res., vol. 8, no. 3, pp. 145–148, 2022, doi: 10.14710/jbtr.v8i3.16046. DOI: https://doi.org/10.14710/jbtr.v8i3.16046

C. G. Pattinasarany, N. Riyanti, H. Rahawarin, A. Resnawaldi, J. Sinanu, and M. M. Maelissa, “Karakteristik Status Obstetri Pada Pasien Mioma Uteri Di Rsud Dr. M. Haulussy Ambon Tahun 2018-2021,” PAMERI Pattimura Med. Rev., vol. 5, no. 1, pp. 31–39, 2023, doi: 10.30598/pamerivol5issue1page31-39. DOI: https://doi.org/10.30598/pamerivol5issue1page31-39

Y. A. Romadhon and Y. P. Kurniati, “Pathway Pengaruh Lingkungan dalam Inisiasi dan Progresivitas Kanker Tulang dan Jaringan Lunak,” Muhammadiyah University Press, 1st, 2024, ISBN 678-602-361-642.

A. S. Dzakwan, N. F. Ngo, H. Nugroho, A. R. Magdaleni, and E. Sawitri, “Hubungan Paritas, IMT, Usia Menarche, Hipertensi, dan Riwayat Keluarga dengan Kejadian Mioma Uteri di RSUD Abdul Wahab Sjahranie Samarinda,” J. Verdure, vol. 3, no. 1, pp. 45–56, 2021.

A. M. Handayani, A. A. P. F. Sari, and R. Ulandari, “Hubungan Usia Menarche Dengan Mioma Uteri Di Rs Sungai Kambang,” Midwifery Heal. J., vol. 8, no. 1, 2023, doi: 10.52524/midwiferyhealthjournal.v8i1.178. DOI: https://doi.org/10.52524/midwiferyhealthjournal.v8i1.178

R. Sahari, “Hubungan Paritas Dengan Kejadian Mioma Uteri Di Rumah Sakit Abdul Manap Kota Jambi Rini,” J. Kesehatan., 2022.

P. N. Lubis, “Diagnosis dan Tatalaksana Mioma Uteri,” Cermin Dunia Kedokt., vol. 47, no. 3, pp. 1–5, 2020. DOI: https://doi.org/10.55175/cdk.v47i3.352

S. H. Amalia et al., “Faktor-faktor yang Memengaruhi Menarche Dini pada Remaja Perempuan Factors Influencing Early Menarche in Adolescent Girls,” J. Medula, vol. 14, pp. 2236–2248, 2024.

K. and R. Handayani, “Gambaran Kesiapan Remaja Dalam Menghadapi Menarche Di Sdit Aisyiyah Full Day Pandes Wedi Klaten,” J. Kebidanan, vol. 8, no. 01, pp. 37–47, 2016, doi: 10.35872/jurkeb.v8i01.198. DOI: https://doi.org/10.35872/jurkeb.v8i01.198

M. Hipson, E. K. Anggraini, P. Studi, D. Kebidanan, and S. A. Palembang, “Analisis Faktor-Faktor Yang Berhubungan Dengan Persalinan Normal,” vol. 13, no. 2, pp. 89–100, 2021. DOI: https://doi.org/10.36729/bi.v13i2.747

R. Sparic, L. Mirkovic, A. Malvasi, and A. Tinelli, “Epidemiology of uterine myomas: A review,” Int. J. Fertil. Steril., vol. 9, no. 4, pp. 424–435, 2016.

A. Ciavattini et al., “Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction,” Obstet. Gynecol. Int., vol. 2013, pp. 1–11, 2013, doi: 10.1155/2013/173184. DOI: https://doi.org/10.1155/2013/173184

Nufra, Y. A., & Azimar, A. (2018). Hubungan Faktor Risiko dengan Kejadian Leimioma Uteri di RSUD dr. Zainoel Abidin Banda Aceh. Journal Of Healthcare Technology And Medicine, 4(2). https://doi.org/10.33143/jhtm.v4i2.217 DOI: https://doi.org/10.33143/jhtm.v4i2.217

N. Nadila and N. N. Zulala, “Faktor-faktor yang berhubungan dengan kejadian mioma uteri di RS PKU Muhammadiyah Gamping , Sleman Yogyakarta Factors related to the incident of uterine myoma at PKU Muhammadiyah Gamping Hospital , Sleman Yogyakarta,” Pros. Semin. Nas. Penelit. dan Pengabdi. Kpd. Masy., vol. 2, no. September, pp. 1220–1228, 2024.

Y. Duan et al., “Correlation between inflammatory marker and lipid metabolism in patients with uterine leiomyomas,” Front. Med., vol. 10, no. May, pp. 1–9, 2023, doi: 10.3389/fmed.2023.1124697. DOI: https://doi.org/10.3389/fmed.2023.1124697

Downloads

Published

2025-12-29

How to Cite

Elvina Fawwaz Maharizdihar, & Yuni Prastyo Kurniati. (2025). The Role of Menarcheal Age and Parity in the Development of Uterine Leiomyoma. Journal of Health Sciences and Medical Development, 4(03), 144–154. https://doi.org/10.56741/hesmed.v4i03.1415

Plaudit